These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39266996)

  • 1. Identification of zinc finger MIZ-type containing 2 as an oncoprotein enhancing NAD-dependent protein deacetylase sirtuin-1 deacetylase activity to regulate Wnt and Hippo pathways in non-small-cell lung cancer.
    Gan X; Feng Y; Liu Y; Lin X; Yu X; Rong X; Han Q
    Cell Mol Biol Lett; 2024 Sep; 29(1):122. PubMed ID: 39266996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
    J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
    Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
    He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
    Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
    Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway.
    Lee SH; Zhu C; Peng Y; Johnson DT; Lehmann L; Sun Z
    J Biol Chem; 2013 Dec; 288(50):35913-24. PubMed ID: 24174533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
    Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
    J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
    J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.
    Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH
    J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
    Hu Y; Mu H; Yang Y
    Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated expression of TIPE3 inhibits malignant progression of non-small cell lung cancer via Wnt signaling.
    Zong Z; Tang G; Guo Y; Kong F
    Exp Cell Res; 2024 Jun; 439(2):114093. PubMed ID: 38759744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
    Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
    Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.
    Zhao W; Zhang LN; Wang XL; Zhang J; Yu HX
    FASEB J; 2019 Jan; 33(1):1151-1166. PubMed ID: 30148675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1.
    Chen J; Chen K; Zhang S; Huang X
    Sci Rep; 2024 Aug; 14(1):19948. PubMed ID: 39198693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
    Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.